Research Highlights

作者
Quan Yao Ho,Fadi Issa
出处
期刊:Transplantation [Wolters Kluwer]
卷期号:107 (12): 2447-2448
标识
DOI:10.1097/tp.0000000000004867
摘要

Implantable Bioelectronic Systems for Early Detection of Kidney Transplant Rejection Madhvapathy SR, Wang JJ, Wang H, et al. Science. 2023;381(6662):1105–1112. Early detection of transplant rejection is key for timely diagnosis and treatment to prevent functional deterioration of graft loss. Existing noninvasive biomarkers, derived from blood or urine, are limited by suboptimal sensitivity and specificity and may only detect rejection when significant graft injury has already occurred.1 Madhvapathy et al introduced a fully implantable, wireless, bioelectronic device that can provide real-time, continuous, long-term monitoring for kidney allograft injury in a rat kidney transplant model.2 The device, implanted on the surface of kidneys, measures local organ temperature and thermal conductivity and appears to be unaffected by changes in the ambient temperature. By comparing native, isogenic transplanted and allogenic transplanted kidneys, the authors demonstrated that changes in local organ temperature, such as a characteristic transient rise and fall of temperature and a greater within-day temperature variation, correlated with histological evidence of rejection. Importantly, these changes can precede elevations in serum creatinine and urea by up to 3 wk when immunosuppression was withdrawn. An intriguing aspect to consider in the future will be how these within-day temperature variations may reflect the circadian rhythms of the immune system and the cycles of immune activation, tissue injury, and tissue repair.3 Although further research is needed before the device can be translated for human use, this study establishes that monitoring local organ temperature could be a promising surrogate for indicators of organ perfusion and inflammation. The potential of a device that can monitor for local organ immune injury continuously in real time is a significant step forward, with possible applications for both transplant and nontransplant settings. The device may also provide an early warning of poor compliance with immunosuppression, subclinical rejection, and other conditions that impact organ blood flow, such as hypovolemia. Nevertheless, key questions remain, such as the efficacy of device in detecting borderline or chronic rejection, as well as its ability to differentiate between rejection and other inflammatory processes like infection.4 Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial Limaye AP, Budde K, Humar A, et al. JAMA. 2023;330(1):33–42. Cytomegalovirus (CMV) infection remains an important cause of morbidity and mortality in solid organ transplant recipients.1 Valganciclovir, the current standard of care for prophylaxis against CMV infection, is effective but associated with toxicity, most notably myelosuppression requiring drug interruption or discontinuation. Letermovir, a CMV DNA terminase complex inhibitor, has been shown to be safe and effective for CMV prophylaxis in adult CMV-seropositive allogenic hematopoietic stem cell transplant recipients.2 However, its use in high-risk, CMV-seronegative solid organ transplant recipients is unproven. In this international, multicenter, double-masked, double-dummy, noninferiority, phase III, randomized controlled trial, 601 high-risk kidney transplant recipients, defined as CMV-seronegative patients who received a kidney from a CMV-seropositive donor, were randomized to receive oral letermovir or oral valganciclovir for up to 200 d and followed up for 52 wk.3 Letermovir was found to be noninferior to valganciclovir for the prevention of CMV disease, as assessed by an external independent masked clinical adjudication committee, with lower rates of leukopenia and neutropenia. Similarly, there were no differences in the rates of investigator-reported CMV disease and CMV DNAaemia. Importantly, none of the participants in the letermovir arm developed CMV disease within the period of prophylaxis, compared with 5 participants in the valganciclovir arm, including 3 who developed CMV DNAaemia while receiving prophylaxis and 2 who developed CMV disease after early discontinuation of prophylaxis. No known letermovir resistance-associated substitutions in viral terminase proteins (pUL51, pUL56, or pUL89) were found in the letermovir group, whereas 12.1% of participants in the valganciclovir group were found to have valganciclovir resistance-associated substitutions in the viral kinase protein (pUL97) and/or the viral DNA polymerase protein (pUL54). Other clinical events, such as rejection, graft loss, and mortality, were too infrequent to be compared meaningfully. The study clearly supports the use of letermovir for prophylaxis against CMV disease in high-risk kidney transplant recipients, although longer-term outcomes and cost-effectiveness remain unclear. Importantly, the study demonstrated lower rates of leukopenia and neutropenia when compared with valganciclovir, as well as no evidence of drug resistance. With the advent of CMV prophylaxis strategies guided by CMV-specific cell immunity assays, further research will be needed to clarify the optimal strategy to prevent CMV infection.4,5
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
mllll发布了新的文献求助10
3秒前
香蕉不惜完成签到,获得积分20
4秒前
4秒前
5秒前
5秒前
5秒前
我是屈原在世完成签到,获得积分10
6秒前
luoshikun发布了新的文献求助10
6秒前
6秒前
六开心完成签到,获得积分10
7秒前
亦芝狐完成签到,获得积分10
7秒前
淡泊宁静完成签到 ,获得积分10
7秒前
柚子发布了新的文献求助10
8秒前
8秒前
9秒前
9秒前
lhm完成签到 ,获得积分10
9秒前
10秒前
无花果的应助被zy采纳,获得10
10秒前
xiaoX12138发布了新的文献求助10
10秒前
精明依云发布了新的文献求助10
11秒前
专一的弱完成签到,获得积分10
11秒前
11秒前
希望天下0贩的0的应助被Johnny采纳,获得10
11秒前
12秒前
Heven88发布了新的文献求助10
12秒前
12秒前
12秒前
12秒前
风中小丸子完成签到,获得积分10
12秒前
13秒前
可爱的函函的应助被paopao采纳,获得10
13秒前
13秒前
molihuakai的应助被ZZXX采纳,获得10
13秒前
Aurora完成签到 ,获得积分10
13秒前
小队昵称完成签到,获得积分10
14秒前
伽玛伽玛完成签到 ,获得积分10
15秒前
starcraftfan完成签到,获得积分10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181892
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818984
捐赠科研通 7778258
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557720
邀请新用户注册赠送积分活动 2479621